SavedAdd your journal

Journals / Çocuk Acil ve Yoğun Bakım Dergisi / 2019 / Cilt: 6 - Sayı: 2

Cerebral Salt-Wasting Syndrome in a Patient with Subacute Sclerosing Panencephalitis: The Use of Fludrocortisone in Treatment

Orkun TOLUNAY
Tamer ÇELİK
Aysu İlhan YALAKİ
Duygu ARTAR
Ümit ÇELİK
Pages
102–104
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we present a 16-year-old male patient, who was followed with the diagnosis of subacute sclerosing panencephalitis and developed CSWS and did not recover from hyponatremia despite sodium replenishment, and was successfully treated with fludrocortisone.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cerebral salt wasting syndrome (CSWS) is characterized by natriuresis and associated with hypovolemia, and hyponatremia.
📊
Key Findings & Data:As the awareness of CSWS, which is frequently described in neurosurgical patient, increases, the number of patients diagnosed increases and new factors are gradually defined in the etiology.
💡
Conclusion & Impact:In this study, we present a 16-year-old male patient, who was followed with the diagnosis of subacute sclerosing panencephalitis and developed CSWS and did not recover from hyponatremia despite sodium replenishment, and was successfully treated with fludrocortisone.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Cerebral salt wasting syndrome (CSWS) is characterized by natriuresis and associated with hypovolemia, and hyponatremia. The underlying pathogenesis is not clearly known. It is often confused with syndrome of inappropriate anti-diuretic hormone release. Volume repletion and sodium replenishment and correction of the underlying cause are the most important components of treatment. As the awareness of CSWS, which is frequently described in neurosurgical patient, increases, the number of patients diagnosed increases and new factors are gradually defined in the etiology. In this study, we present a 16-year-old male patient, who was followed with the diagnosis of subacute sclerosing panencephalitis and developed CSWS and did not recover from hyponatremia despite sodium replenishment, and was successfully treated with fludrocortisone.

🔖

Cite This Article

TOLUNAY, O., ÇELİK, T., YALAKİ, A. İ., ARTAR, D., ÇELİK, Ü. (2019). Cerebral Salt-Wasting Syndrome in a Patient with Subacute Sclerosing Panencephalitis: The Use of Fludrocortisone in Treatment. Çocuk Acil ve Yoğun Bakım Dergisi, Cilt: 6 - Sayı: 2, 102–104. https://ajindex.com/articles/151766

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Oh JY, Shin JI. Syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome: similarities and differences. Front Pediatr. 2015;22;146
  2. Celik T, Tolunay O, Tolunay I, Celik U. Cerebral Salt Wasting in Status Epilepticus: Two Cases and Review of the Literature. Pediatr Neurol. 2014;50:397-9
  3. Thompson C, Berl T, Tejedor A, Johannsson G. Differential diagnosis of hyponatraemia. Best Pract Res Clin Endocrinol Metab. 2012;26:7-15
  4. Rivkees SA. Differentiating appropriate antidiuretic hormone secretion, inappropriate antidiuretic hormone secretion and cerebral salt wasting: the common, uncommon, and misnamed. Curr Opin Pediatr. 2008;20:448-52
  5. Diringer M, Ladenson W, Borel C, Hart GK, Kirsch JR, et al. Sodium and water regulation in a patient with cerebral salt wasting. Arch Neurol. 1989;46:928-30
  6. Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 1957;23:529-42
  7. PETERS JP, WELT LG, SIMS EA, ORLOFF J, NEEDHAM J. A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians. 1950;63:57-64
  8. Nelson PB, Seif SM, Maroon JC, Robinson AG. Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Neurosurg. 1981;55:938–41
  9. Palmer, B.F. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab. 2003;14:182-7
  10. Berkenbosch JW, Lentz CW, Jimenez DF, Tobias JD. Cerebral salt wasting syndrome following brain injury in three pediatric patients: suggestions for rapid diagnosis and therapy. Pediatr Neurosurg. 2002;36:75-9
  11. Tolunay O, Çelik T, Çelik Ü, Kömür M, Yağcı-Küpeli B. Cerebral salt wasting in pediatric critical care; not just a neurosurgical disorder anymore. Neuro Endocrinol Lett. 2015;36:578-82
  12. Doczi TP, Joo F, Balas I. Atrial natriuretic peptide (ANP) attenuates brain oedema accompanying experimental subarachnoid haemorrhage. Acta Neurochir (Wien). 1995;132:87-91
  13. Berendes E, Walter M, Cullen P, Pirien T, Van Aken H, et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet. 1997;349:245-9
  14. Çalık M, İşcan A, Abuhandan M, Geter S, Ataş A, et al. Cerebral salt wasting syndrome in a child with SSPE. J Pediatr Neurol. 2012;10:221-24
  15. Jimenez R, Casado-Flores J, Nieto M, García-T